Summit (Israel) Investor Sentiment

SMT Stock  ILS 6,009  36.00  0.60%   
About 52% of Summit's investor base is interested to short. The analysis of current outlook of investing in Summit suggests that many traders are impartial regarding Summit's prospects. The current market sentiment, together with Summit's historical and current headlines, can help investors time the market. In addition, many technical investors use Summit stock news signals to limit their universe of possible portfolio assets.
  
over three months ago at news.google.com         
Summit Therapeutics Hurt Bronte Capital. Heres Why - Insider Monkey
Google News at Macroaxis
over three months ago at news.google.com         
Summit Midstream CEO sells 107,060 in stock - Investing.com
Google News at Macroaxis
over three months ago at news.google.com         
Summit Partners sells 114 million in Klaviyo stock - Investing.com
Google News at Macroaxis
over three months ago at news.google.com         
Dimon Has a Tariff Tip as Trump Haunts CEO Summit - Bloomberg
Google News at Macroaxis
over three months ago at news.google.com         
Merck Spends Up To 3.3 Billion In An Insurance Policy Against Summit Therapeutics - Investors Busine...
Google News at Macroaxis
over three months ago at news.google.com         
Why Summit Therapeutics Stock Was a Winner Today - The Motley Fool
Google News at Macroaxis
over three months ago at news.google.com         
Up Over 600 percent in 2024, Can Summit Therapeutics Stock Keep Rising - The Motley Fool
Google News at Macroaxis
over three months ago at news.google.com         
Summit Stock Skyrockets Nearly 700 percent YTD Time to Sell or Hold - Yahoo Finance
Google News at Macroaxis
over three months ago at news.google.com         
Summit Midstream to buy Tall Oak Midstream in 450M cash and stock deal - Seeking Alpha
Google News at Macroaxis
over three months ago at news.google.com         
Is Summit Therapeutics Stock a Buy - The Motley Fool
Google News at Macroaxis
over three months ago at news.google.com         
Is Summit Materials, Inc. the Best Construction Stock To Buy According to Analysts - Insider Monkey
Google News at Macroaxis
over three months ago at news.google.com         
Is Summit Therapeutics Inc. the Best Performing Stock in 2024 - Yahoo Finance
Google News at Macroaxis
over three months ago at news.google.com         
SUMMIT HOTEL PROPERTIES ANNOUNCES THIRD QUARTER 2024 EARNINGS RELEASE DATE - StockTitan
Google News at Macroaxis
over three months ago at news.google.com         
Why Summit Therapeutics Stock Is Rising Today - Benzinga
Google News at Macroaxis
over three months ago at news.google.com         
Summit Therapeutics stock pops as cancer drug beats Merck blockbuster in trial - MarketWatch
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Summit that are available to investors today. That information is available publicly through Summit media outlets and privately through word of mouth or via Summit internal channels. However, regardless of the origin, that massive amount of Summit data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Summit news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Summit relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Summit's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Summit alpha.

Summit Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Summit Stock analysis

When running Summit's price analysis, check to measure Summit's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Summit is operating at the current time. Most of Summit's value examination focuses on studying past and present price action to predict the probability of Summit's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Summit's price. Additionally, you may evaluate how the addition of Summit to your portfolios can decrease your overall portfolio volatility.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance